Pune, Maharastra -- (SBWIRE) -- 12/04/2015 -- This "Biosimilar (Insulin) - Competitive Landscape and Market & Pipeline Analysis, 2015" discusses the global insulin biosimilar market. Report analyzes that Insulin and Insulin Biosimilars holds a future scope and potential in the market. It highlights the market trends, regulatory requirements for US and EU and key domestic players.

Report provides an insight on Insulin Biosimilars that are under development for Type 1 and Type 2 Diabetes with an insight on the Epidemiology of the disease. It provides detailed information on the 11 Insulin Biosimilar that are in pipeline.

It analyses Insulin Biosimilar market and discusses the key market trends, major players, market assessment of 6 marketed insulin and the types of insulin with the length activity available in market.

Complete report available at http://www.marketreportsonline.com/431470.html.

Scope
- Coverage of global insulin biosimilar under development across the globe
- Sales forecast for marketed insulin from 2015 to 2017
- Detailed information on product description and related stage of development, the mode of therapy, mechanism of action, development partner and technology information.
- The report discusses the biosimilar regulatory landscape of various markets including developed markets of the US and EU
- Report analyses the types of insulin under development with respect to their market share and length of activity

Reasons to buy
- The insulin biosimilar report covers complete Pipeline intelligence and understanding over therapeutics development for insulin market.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of insulin under development
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding the insulin biosimilar pipeline in-depth
- Identifying the upcoming leaders in the insulin biosimilar market in the coming year

Purchase a copy of biosimilar market research report at USD 1450 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=431470.

Few Points From List of Tables

Table 1:Marketed Insulin Details, 2015
Table 8: Historical Global Sales of Marketed Insulin Analogs 2011-2014 (in million USD), 2015
Table 9: Forecasted Global Sales of Marketed Insulin Analogs 2015-2017 (in million USD), 2015
Table 10:Number of Products Under Development for Insulin Biosimilars,2015
Table 11: Number of Products under Development by Companies,2015
Table 12: Late Stage Products (Phase III and Filed), 2015
Table 13: Early Stage Products (Phase I and IND),2015
Table 14: Pre-Clinical and Discovery Products, 2015
Table 15: Assessment by Monotherapy Products, 2015
Table 16: Assessment by Combination Products, 2015
Table 17: Assessment by Route Of Administration, 2015
Table 18:Assessment by Stage and Route Of Administration, 2015
Table 19: Assessment by Molecule Type, 2015
Table 20: Assessment by Stage and Molecule Type, 2015
Table 21: Dormant Products, 2015

Browse All Pharmaceuticals Market Research Reports at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About MarketReportsOnline
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com